新产品上线! Email验证工具 - 限时免费试用中立即试用

外贸营销群发邮件之前,先批量验证邮箱地址是否有效,可节省成本,提高发送成功率,减少被列入黑名单风险。 更多需求:邮箱采集/邮件群发

附件XVII第28-30条限制致癌、致突变和生殖毒性物质(CMR)。当这些物质存在于物品中时,这些限制是否适用?

问题(中文)
附件XVII第28-30条限制致癌、致突变和生殖毒性物质(CMR)。当这些物质存在于物品中时,这些限制是否适用?
Question (EN)
Entries 28-30 of Annex XVII restrict substances that are carcinogenic, mutagenic and toxic to reproduction (CMR). Do these restrictions apply to these substances when they are present in articles?
中文内容由 Google Cloud Translation 自动生成,仅供参考;请以英文原文为准。问答资料来自欧盟化学品管理局(ECHA)官方网站。
答案(中文)
第28-30条所列物质不得作为物质、其他物质的成分或混合物投放市场或用于向公众供应,前提是其浓度等于或高于规定的限值。此限制适用第2款列出的某些例外情况。存在于物品中的CMR物质不属于第28-30条所规定的限制范围,但这些物质存在于物品中时,可能适用其他限制。此外,可能适用REACH法规下的通知和通报义务;请参阅ECHA网站:https://echa.europa.eu/regulations/reach/candidate-list-substances-in-articles/notification-of-substances-in-articles。需要注意的是,条目28和29适用于附录1和2(致癌性(C),1A和1B类)以及附录3和4(致突变性(M),1A和1B类)中列出的物质。条目30适用于被归类为生殖毒性(R),1A和1B类并列于附录5和6中的物质。根据第1272/2008号法规,在采用CMR、1A或1B类物质的协调分类后,这些附录会定期更新,纳入新的物质。
Answer (EN)
Substances within the scope of entries 28-30 are not allowed to be placed on the market or used for supply to the general public as substances, as constituents of other substances or in mixtures when the concentration is equal to or greater than the specified limits. Certain derogations apply to this restriction as listed in paragraph 2. CMR substances that are present in articles are not within the scope of the restriction imposed by entries 28-30, but other restrictions may be applicable to these substances, when present in articles. In addition, notification and communication obligations under REACH may apply; see the ECHA website: https://echa.europa.eu/regulations/reach/candidate-list-substances-in-articles/notification-of-substances-in-articles. It should be noted that entries 28 and 29 are applicable to the substances that are listed in Appendices 1 & 2 (carcinogenic (C), categories 1A and 1B) and Appendices 3 & 4 (mutagenic (M), categories 1A and 1B). Entry 30 is applicable to substances which are classified as reproductive toxicants (R), categories 1A and 1B and listed in Appendices 5 and 6. These Appendices are regularly updated by including new substances, after the adoption of a harmonised classification for a substance as CMR, category 1A or 1B according to Regulation (EC) No 1272/2008.